Kentucky Attorney General Sues GlaxoSmithKline for False Claims

Kentucky's attorney general has joined in the flurry of legal action against GlaxoSmithKline, filing a lawsuit accusing the company of concealing the cardiovascular risks associated with a diabetes drug.

The suit claims that GlaxoSmithKline LLC violated the state's Consumer Protection Act by overstating the effectiveness of the prescription drug Avandia and hiding its risks from consumers. Instead of reducing cardiovascular risks faced by diabetics, as the drug maker claimed, the one-time blockbuster drug actually increases those risks, Attorney General Jack Conway said Thursday.

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization of two cancer drugs.

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.